Status:
COMPLETED
Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring
Lead Sponsor:
Northwestern University
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18-65 years
Brief Summary
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patient's aged 18-65
- Patient's scheduled to undergo a Trans-thoracic Echocardiogram (TTE) in an outpatient cardiology clinic or admitted to the Cardiac Care Unit with a swan ganz catheter in place for continuous invasive hemodynamic monitoring
- Exclusion Criteria
- Patient's with fragile skin or skin conditions that would prevent them from having a sensor placed
- Patients undergoing exercise or drug induced cardiac stress test
- Patients with a visible wound at site of sensor placement 3.4. Patients with structural or functional limitations to peripheral blood flow (known upper extremity peripheral arterial disease, use of vasopressors etc.).
Exclusion
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 5 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04362553
Start Date
June 1 2020
End Date
September 5 2022
Last Update
September 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611